right-img

Home | Investment Analysts’ Downgrades for March, 1st (AGIO, AMSSY, BGNE, CBG, CRQDF, ENBL, FOJCY, FRTA, GBGPF, SEPGY)

Investment Analysts’ Downgrades for March, 1st (AGIO, AMSSY, BGNE, CBG, CRQDF, ENBL, FOJCY, FRTA, GBGPF, SEPGY)

March 01, 2021
Investment Analysts’ downgrades for Monday, March 1st: Agios Pharmaceuticals (NASDAQ:AGIO) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. JPMorgan Chase & Co. currently has $54.00 target price on the stock, down from their previous target price of $64.00. AMS (OTCMKTS:AMSSY) was downgraded by analysts at Deutsche […]
Read more at:https://www.americanbankingnews.com/2021/03/01/investment-analysts-downgrades-for-march-1st-agio-amssy-bgne-cbg-crqdf-enbl-fojcy-frta-gbgpf-sepgy.html

Site Created by finaceandbankingnewsnow.com